Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2020
Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell TumorKoichi Ogura, Romel Somwar, Julija Hmeljak, et al.Nature Medicine|February 7, 2017
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samplesLuciano G Martelotto, Timour Baslan, Jude Kendall, et al.Proceedings of the National Academy of Sciences of the United States of America|June 8, 2018
YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomicsPang-Dian Fan, Giuseppe Narzisi, Anitha D Jayaprakash, et al.Disease Models & Mechanisms|November 29, 2021
Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signalingRoger S Smith, Igor Odintsov, Zebing Liu, et al.Cancer Discovery|March 17, 2019
Patient-Driven Discovery, Therapeutic Targeting, and Post-Clinical Validation of a Novel AKT1 Fusion-Driven CancerEmily K Slotkin, Daniel Diolaiti, Neerav N Shukla, et al.Emerging Microbes & Infections|October 23, 2023
Previous exposure to Spike-providing parental strains confers neutralizing immunity to XBB lineage and other SARS-CoV-2 recombinants in the context of vaccinationRahul K Suryawanshi, Taha Y Taha, Maria McCavitt-Malvido, et al.Medrxiv : the Preprint Server for Health Sciences|January 25, 2022
Limited Cross-Variant Immunity after Infection with the SARS-CoV-2 Omicron Variant Without VaccinationRahul K Suryawanshi, Irene P Chen, Tongcui Ma, et al.Nature|May 18, 2022
Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccinationRahul K Suryawanshi, Irene P Chen, Tongcui Ma, et al.Pageof 5